Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where J. Luan is active.

Publication


Featured researches published by J. Luan.


PLOS Genetics | 2010

Genome-wide association study of blood pressure extremes identifies variant near UMOD associated with hypertension

Sandosh Padmanabhan; Olle Melander; Toby Johnson; A. M. Di Blasio; Wai Kwong Lee; Davide Gentilini; Claire E. Hastie; C. Menni; M.C. Monti; Christian Delles; S. Laing; B. Corso; Gerarda Navis; A.J. Kwakernaak; P. van der Harst; Murielle Bochud; Marc Maillard; Michel Burnier; Thomas Hedner; Sverre E. Kjeldsen; Björn Wahlstrand; Marketa Sjögren; Cristiano Fava; Martina Montagnana; Elisa Danese; Ole Torffvit; Bo Hedblad; Harold Snieder; John M. Connell; Matthew A. Brown

Hypertension is a heritable and major contributor to the global burden of disease. The sum of rare and common genetic variants robustly identified so far explain only 1%–2% of the population variation in BP and hypertension. This suggests the existence of more undiscovered common variants. We conducted a genome-wide association study in 1,621 hypertensive cases and 1,699 controls and follow-up validation analyses in 19,845 cases and 16,541 controls using an extreme case-control design. We identified a locus on chromosome 16 in the 5′ region of Uromodulin (UMOD; rs13333226, combined P value of 3.6×10−11). The minor G allele is associated with a lower risk of hypertension (OR [95%CI]: 0.87 [0.84–0.91]), reduced urinary uromodulin excretion, better renal function; and each copy of the G allele is associated with a 7.7% reduction in risk of CVD events after adjusting for age, sex, BMI, and smoking status (H.R. = 0.923, 95% CI 0.860–0.991; p = 0.027). In a subset of 13,446 individuals with estimated glomerular filtration rate (eGFR) measurements, we show that rs13333226 is independently associated with hypertension (unadjusted for eGFR: 0.89 [0.83–0.96], p = 0.004; after eGFR adjustment: 0.89 [0.83–0.96], p = 0.003). In clinical functional studies, we also consistently show the minor G allele is associated with lower urinary uromodulin excretion. The exclusive expression of uromodulin in the thick portion of the ascending limb of Henle suggests a putative role of this variant in hypertension through an effect on sodium homeostasis. The newly discovered UMOD locus for hypertension has the potential to give new insights into the role of uromodulin in BP regulation and to identify novel drugable targets for reducing cardiovascular risk.


Nature Genetics | 2009

Genetic variation in LIN28B is associated with the timing of puberty

Ken K. Ong; Cathy E. Elks; Shengxu Li; Jing Hua Zhao; J. Luan; Lars Bo Andersen; Sheila Bingham; Soren Brage; George Davey Smith; Ulf Ekelund; Christopher J Gillson; Beate Glaser; Jean Golding; Rebecca Hardy; Kay-Tee Khaw; Diana Kuh; Robert Luben; Michele Marcus; Michael A. McGeehin; Andy R Ness; Kate Northstone; Susan M. Ring; Carol Rubin; Matthew Sims; Kijoung Song; David P. Strachan; Peter Vollenweider; Gérard Waeber; Dawn M. Waterworth; Andrew Wong

The timing of puberty is highly variable. We carried out a genome-wide association study for age at menarche in 4,714 women and report an association in LIN28B on chromosome 6 (rs314276, minor allele frequency (MAF) = 0.33, P = 1.5 × 10−8). In independent replication studies in 16,373 women, each major allele was associated with 0.12 years earlier menarche (95% CI = 0.08–0.16; P = 2.8 × 10−10; combined P = 3.6 × 10−16). This allele was also associated with earlier breast development in girls (P = 0.001; N = 4,271); earlier voice breaking (P = 0.006, N = 1,026) and more advanced pubic hair development in boys (P = 0.01; N = 4,588); a faster tempo of height growth in girls (P = 0.00008; N = 4,271) and boys (P = 0.03; N = 4,588); and shorter adult height in women (P = 3.6 × 10−7; N = 17,274) and men (P = 0.006; N = 9,840) in keeping with earlier growth cessation. These studies identify variation in LIN28B, a potent and specific regulator of microRNA processing, as the first genetic determinant regulating the timing of human pubertal growth and development.


Diabetologia | 2009

Correlation of the leptin:adiponectin ratio with measures of insulin resistance in non-diabetic individuals

Francis M. Finucane; J. Luan; Nicholas J. Wareham; Stephen J. Sharp; Stephen O’Rahilly; Beverley Balkau; A. Flyvbjerg; M. Walker; Kurt Højlund; John J. Nolan; David B. Savage

Aims/hypothesisObesity is the dominant cause of insulin resistance. In adult humans it is characterised by a combination of adipocyte hypertrophy and, to a lesser extent, adipocyte hyperplasia. As hypertrophic adipocytes secrete more leptin and less adiponectin, the plasma leptin:adiponectin ratio (LAR) has been proposed as a potentially useful measure of insulin resistance and vascular risk. We sought to assess the usefulness of the LAR as a measure of insulin resistance in non-diabetic white adults.MethodsLeptin and adiponectin levels were measured in 2,097 non-diabetic individuals from the Ely and European Group for the Study of Insulin Resistance (EGIR) Relationship between Insulin Sensitivity and Cardiovascular Risk (RISC) study cohorts. LAR was compared with fasting insulin and HOMA-derived insulin sensitivity (HOMA-S) in all individuals and with the insulin sensitivity index (M/I) from hyperinsulinaemic–euglycaemic clamp studies in 1,226 EGIR RISC participants.ResultsThe LAR was highly correlated with HOMA-S in men (r = −0.58, p = 4.5 × 10−33 and r = −0.65, p = 1.1 × 10−66 within the Ely and EGIR RISC study cohorts, respectively) and in women (r = −0.51, p = 2.8 × 10−36 and r = −0.61, p = 2.5 × 10−73). The LAR was also strongly correlated with the clamp M/I value (r = −0.52, p = 4.5 × 10−38 and r = −0.47, p = 6.6 × 10−40 in men and women, respectively), similar to correlations between HOMA-S and the M/I value.Conclusions/interpretationThe leptin:adiponectin ratio is a useful measure of insulin resistance in non-diabetic white adults. These data highlight the central role of adipocyte dysfunction in the pathogenesis of insulin resistance. Given that variations between fasting and postprandial leptin and adiponectin levels tend to be small, the leptin to adiponectin ratio might also have potential value in assessing insulin sensitivity in the non-fasted state.


Journal of Clinical Investigation | 2010

Mutations in the selenocysteine insertion sequence–binding protein 2 gene lead to a multisystem selenoprotein deficiency disorder in humans

Erik Schoenmakers; Maura Agostini; Catherine Mitchell; Nadia Schoenmakers; Laura Vanda Papp; Odelia Rajanayagam; Raja Padidela; Lourdes Ceron-Gutierrez; Rainer Doffinger; Claudia Prevosto; J. Luan; Sergio J. Montano; Jun Lu; Mireille Castanet; Nicholas J. Clemons; Matthijs Groeneveld; Perrine Castets; Mahsa Karbaschi; Sri Aitken; Adrian K. Dixon; Je Williams; Irene Campi; Margaret Blount; Hannah Burton; Francesco Muntoni; Dominic O'Donovan; Andrew Dean; Anne Warren; Charlotte Brierley; David M. Baguley

Selenium, a trace element that is fundamental to human health, is incorporated into some proteins as selenocysteine (Sec), generating a family of selenoproteins. Sec incorporation is mediated by a multiprotein complex that includes Sec insertion sequence-binding protein 2 (SECISBP2; also known as SBP2). Here, we describe subjects with compound heterozygous defects in the SECISBP2 gene. These individuals have reduced synthesis of most of the 25 known human selenoproteins, resulting in a complex phenotype. Azoospermia, with failure of the latter stages of spermatogenesis, was associated with a lack of testis-enriched selenoproteins. An axial muscular dystrophy was also present, with features similar to myopathies caused by mutations in selenoprotein N (SEPN1). Cutaneous deficiencies of antioxidant selenoenzymes, increased cellular ROS, and susceptibility to ultraviolet radiation-induced oxidative damage may mediate the observed photosensitivity. Reduced levels of selenoproteins in peripheral blood cells were associated with impaired T lymphocyte proliferation, abnormal mononuclear cell cytokine secretion, and telomere shortening. Paradoxically, raised ROS in affected subjects was associated with enhanced systemic and cellular insulin sensitivity, similar to findings in mice lacking the antioxidant selenoenzyme glutathione peroxidase 1 (GPx1). Thus, mutation of SECISBP2 is associated with a multisystem disorder with defective biosynthesis of many selenoproteins, highlighting their role in diverse biological processes.


Cell Metabolism | 2006

Non-DNA binding, dominant-negative, human PPARγ mutations cause lipodystrophic insulin resistance

Maura Agostini; Erik Schoenmakers; Catherine Mitchell; Istvan Szatmari; David B. Savage; Aaron G. Smith; Odelia Rajanayagam; Robert K. Semple; J. Luan; Louise Bath; Anthony Zalin; Mourad Labib; S. Kumar; Helen L. Simpson; Dirk Blom; David Marais; John W. R. Schwabe; Inês Barroso; Richard C. Trembath; Nicholas J. Wareham; Laszlo Nagy; Mark Gurnell; Stephen O'Rahilly; Krishna Chatterjee

Summary PPARγ is essential for adipogenesis and metabolic homeostasis. We describe mutations in the DNA and ligand binding domains of human PPARγ in lipodystrophic, severe insulin resistance. These receptor mutants lack DNA binding and transcriptional activity but can translocate to the nucleus, interact with PPARγ coactivators and inhibit coexpressed wild-type receptor. Expression of PPARγ target genes is markedly attenuated in mutation-containing versus receptor haploinsufficent primary cells, indicating that such dominant-negative inhibition operates in vivo. Our observations suggest that these mutants restrict wild-type PPARγ action via a non-DNA binding, transcriptional interference mechanism, which may involve sequestration of functionally limiting coactivators.


Journal of Nutrition | 2009

Adherence to the Mediterranean Diet Is Associated with Lower Abdominal Adiposity in European Men and Women

Dora Romaguera; Teresa Norat; Traci Mouw; Anne M. May; Christina Bamia; Nadia Slimani; Noémie Travier; Hervé Besson; J. Luan; Nicholas J. Wareham; Sabina Rinaldi; Elisabeth Couto; Françoise Clavel-Chapelon; Marie-Christine Boutron-Ruault; Vanessa Cottet; Domenico Palli; Claudia Agnoli; Salvatore Panico; Rosario Tumino; Paolo Vineis; Antonio Agudo; Laudina Rodríguez; Maria José Sánchez; Pilar Amiano; Aurelio Barricarte; José María Huerta; Timothy J. Key; Elizabeth A. Spencer; H. Bas Bueno-de-Mesquita; Frederike L. Büchner

Given the lack of consistent evidence of the relationship between Mediterranean dietary patterns and body fat, we assessed the cross-sectional association between adherence to a modified Mediterranean diet, BMI, and waist circumference (WC). A total of 497,308 individuals (70.7% women) aged 25-70 y from 10 European countries participated in this study. Diet was assessed at baseline using detailed validated country-specific questionnaires, and anthropometrical measurements were collected using standardized procedures. The association between the degree of adherence to the modified-Mediterranean Diet Score (mMDS) (including high consumption of vegetables, legumes, fruits and nuts, cereals, fish and seafood, and unsaturated:saturated fatty acids ratio; moderate alcohol intake; and low consumption of meat and meat products and dairy products) and BMI (kg.m(-2)) or WC (cm) was modeled through mixed-effects linear regression, controlling for potential confounders. Overall, the mMDS was not significantly associated with BMI. Higher adherence to the Mediterranean diet was significantly associated with lower WC, for a given BMI, in both men (-0.09; 95% CI -0.14 to -0.04) and women (-0.06; 95% CI -0.10 to -0.01). The association was stronger in men (-0.20; 95% CI -0.23 to -0.17) and women (-0.17; 95% CI -0.21 to -0.13) from Northern European countries. Despite the observed heterogeneity among regions, results of this study suggest that adherence to a modified Mediterranean diet, high in foods of vegetable origin and unsaturated fatty acids, is associated with lower abdominal adiposity measured by WC in European men and women.


The American Journal of Clinical Nutrition | 2010

Mediterranean dietary patterns and prospective weight change in participants of the EPIC-PANACEA project

Dora Romaguera; Teresa Norat; Anne Claire Vergnaud; Traci Mouw; Anne M. May; Antonio Agudo; Genevieve Buckland; Nadia Slimani; Sabina Rinaldi; Elisabeth Couto; Françoise Clavel-Chapelon; Marie Christine Boutron-Ruault; Vanessa Cottet; Sabine Rohrmann; Birgit Teucher; Manuela M. Bergmann; Heiner Boeing; Anne Tjønneland; Jytte Halkjær; Marianne Uhre Jakobsen; Christina C. Dahm; Noémie Travier; Laudina Rodríguez; María José Sánchez; Pilar Amiano; Aurelio Barricarte; José María Huerta; J. Luan; Nicholas J. Wareham; Timothy J. Key

BACKGROUND There is an association between a greater adherence to a Mediterranean diet and a reduced risk of developing chronic diseases. However, it is not clear whether this dietary pattern may be protective also against the development of obesity. OBJECTIVE We assessed the association between the adherence to the Mediterranean dietary pattern (MDP), prospective weight change, and the incidence of overweight or obesity. DESIGN We conducted a prospective cohort study [the European Prospective Investigation into Cancer and Nutrition-Physical Activity, Nutrition, Alcohol Consumption, Cessation of Smoking, Eating Out of Home, and Obesity (EPIC-PANACEA) project] in 373,803 individuals (103,455 men and 270,348 women; age range: 25-70 y) from 10 European countries. Anthropometric measurements were obtained at recruitment and after a median follow-up time of 5 y. The relative Mediterranean Diet Score (rMED; score range: 0-18) was used to assess adherence to the MDP according to the consumption of 9 dietary components that are characteristic of the Mediterranean diet. The association between the rMED and 5-y weight change was modeled through multiadjusted mixed-effects linear regression. RESULTS Individuals with a high adherence to the MDP according to the rMED (11-18 points) showed a 5-y weight change of -0.16 kg (95% CI: -0.24, -0.07 kg) and were 10% (95% CI: 4%, 18%) less likely to develop overweight or obesity than were individuals with a low adherence to the MDP (0-6 points). The low meat content of the Mediterranean diet seemed to account for most of its positive effect against weight gain. CONCLUSION This study shows that promoting the MDP as a model of healthy eating may help to prevent weight gain and the development of obesity.


The American Journal of Clinical Nutrition | 2010

Meat consumption and prospective weight change in participants of the EPIC-PANACEA study

Anne Claire Vergnaud; Teresa Norat; Dora Romaguera; Traci Mouw; Anne M. May; Noémie Travier; J. Luan; Nicholas J. Wareham; Nadia Slimani; Sabina Rinaldi; Elisabeth Couto; Françoise Clavel-Chapelon; Marie Christine Boutron-Ruault; Vanessa Cottet; Domenico Palli; Claudia Agnoli; Salvatore Panico; Rosario Tumino; Paolo Vineis; Antonio Agudo; Laudina Rodríguez; María José Sánchez; Pilar Amiano; Aurelio Barricarte; José María Huerta; Timothy J. Key; Elizabeth A. Spencer; Bas Bueno-de-Mesquita; Frederike L. Büchner; Philippos Orfanos

BACKGROUND Meat intake may be related to weight gain because of its high energy and fat content. Some observational studies have shown that meat consumption is positively associated with weight gain, but intervention studies have shown mixed results. OBJECTIVE Our objective was to assess the association between consumption of total meat, red meat, poultry, and processed meat and weight gain after 5 y of follow-up, on average, in the large European population who participated in the European Prospective Investigation into Cancer and Nutrition-Physical Activity, Nutrition, Alcohol, Cessation of Smoking, Eating Out of Home and Obesity (EPIC-PANACEA) project. DESIGN A total of 103,455 men and 270,348 women aged 25-70 y were recruited between 1992 and 2000 in 10 European countries. Diet was assessed at baseline with the use of country-specific validated questionnaires. A dietary calibration study was conducted in a representative subsample of the cohort. Weight and height were measured at baseline and self-reported at follow-up in most centers. Associations between energy from meat (kcal/d) and annual weight change (g/y) were assessed with the use of linear mixed models, controlled for age, sex, total energy intake, physical activity, dietary patterns, and other potential confounders. RESULTS Total meat consumption was positively associated with weight gain in men and women, in normal-weight and overweight subjects, and in smokers and nonsmokers. With adjustment for estimated energy intake, an increase in meat intake of 250 g/d (eg, one steak at approximately 450 kcal) would lead to a 2-kg higher weight gain after 5 y (95% CI: 1.5, 2.7 kg). Positive associations were observed for red meat, poultry, and processed meat. CONCLUSION Our results suggest that a decrease in meat consumption may improve weight management.


The American Journal of Clinical Nutrition | 2011

Physical activity and gain in abdominal adiposity and body weight: prospective cohort study in 288,498 men and women

Ulf Ekelund; Hervé Besson; J. Luan; Anne M. May; Stephen J. Sharp; Soren Brage; Noémie Travier; Antonio Agudo; Nadia Slimani; Sabina Rinaldi; Mazda Jenab; Teresa Norat; Traci Mouw; Sabine Rohrmann; Rudolf Kaaks; Manuela M. Bergmann; Heiner Boeing; Françoise Clavel-Chapelon; Marie Christine Boutron-Ruault; Kim Overvad; Marianne Uhre Jakobsen; Nina Føns Johnsen; Jytte Halkjær; Carlos A. González; Laudina Rodríguez; Maria José Sánchez; Larraitz Arriola; Aurelio Barricarte; Carmen Navarro; Timothy J. Key

BACKGROUND The protective effect of physical activity (PA) on abdominal adiposity is unclear. OBJECTIVE We examined whether PA independently predicted gains in body weight and abdominal adiposity. DESIGN In a prospective cohort study [the EPIC (European Prospective Investigation into Cancer and Nutrition)], we followed 84,511 men and 203,987 women for 5.1 y. PA was assessed by a validated questionnaire, and individuals were categorized into 4 groups (inactive, moderately inactive, moderately active, and active). Body weight and waist circumference were measured at baseline and self-reported at follow-up. We used multilevel mixed-effects linear regression models and stratified our analyses by sex with adjustments for age, smoking status, alcohol consumption, educational level, total energy intake, duration of follow-up, baseline body weight, change in body weight, and waist circumference (when applicable). RESULTS PA significantly predicted a lower waist circumference (in cm) in men (β = -0.045; 95% CI: -0.057, -0.034) and in women (β = -0.035; 95% CI: -0.056, -0.015) independent of baseline body weight, baseline waist circumference, and other confounding factors. The magnitude of associations was materially unchanged after adjustment for change in body weight. PA was not significantly associated with annual weight gain (in kg) in men (β = -0.008; 95% CI: -0.02, 0.003) and women (β = -0.01; 95% CI: -0.02, 0.0006). The odds of becoming obese were reduced by 7% (P < 0.001) and 10% (P < 0.001) for a one-category difference in baseline PA in men and women, respectively. CONCLUSION Our results suggest that a higher level of PA reduces abdominal adiposity independent of baseline and changes in body weight and is thus a useful strategy for preventing chronic diseases and premature deaths.


International Journal of Obesity | 2009

A cross-sectional analysis of physical activity and obesity indicators in European participants of the EPIC-PANACEA study

Hervé Besson; Ulf Ekelund; J. Luan; Anne May; Stephen J. Sharp; Noémie Travier; Antonio Agudo; Nadia Slimani; S. Rinaldi; Mazda Jenab; Teresa Norat; T Mouw; Sabine Rohrmann; R. Kaaks; M. Bergmann; Heiner Boeing; F. Clavel-Chapelon; M. C. Boutron-Ruault; Kim Overvad; Elizabeth Lykholt Andreasen; N Føns Johnsen; Jytte Halkjær; Clementina González; Laudina Rodríguez; M. J. Sánchez; Larraitz Arriola; Aurelio Barricarte; C. Navarro; Timothy J. Key; Elizabeth A. Spencer

Objectives:Cross-sectional data suggest a strong association between low levels of physical activity and obesity. The EPIC-PANACEA (European Prospective Investigation into Cancer-Physical Activity, Nutrition, Alcohol, Cessation of Smoking, Eating out of home And obesity) project was designed to investigate the associations between physical activity and body mass index (BMI) and waist circumference based on individual data collected across nine European countries.Methods:In the European Prospective Investigation into Cancer and Nutrition (EPIC), 519 931 volunteers were recruited between 1992 and 2000, of whom 405 819 had data on main variables of interest. Height, body weight and waist circumference were measured using standardized procedures. Physical activity was assessed using a validated four-category index reflecting a self-reported usual activity during work and leisure time. The associations between physical activity and BMI and waist circumference were estimated using multilevel mixed effects linear regression models, adjusted for age, total energy intake, smoking status, alcohol consumption and educational level.Results:A total of 125 629 men and 280 190 women with a mean age of 52.9 (s.d. 9.7) and 51.5 (s.d. 10.0) years, respectively were included. The mean BMI was 26.6 kg/m2 (s.d. 3.6) in men and 25.0 kg/m2 (s.d. 4.5) in women. Fifty percent of men and 30% of women were categorized as being active or moderately active. A one-category difference in the physical activity index was inversely associated with a difference of 0.18 kg/m2 in the mean BMI (95% confidence interval, CI, 0.11, 0.24) and 1.04-cm (95% CI 0.82, 1.26) difference in waist circumference in men. The equivalent figures for women were 0.31 kg/m2 (95% CI 0.23, 0.38) and 0.90 cm (95% CI 0.71, 1.08), respectively.Conclusions:Physical activity is inversely associated with both BMI and waist circumference across nine European countries. Although we cannot interpret the association causally, our results were observed in a large and diverse cohort independently from many potential confounders.

Collaboration


Dive into the J. Luan's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Inês Barroso

Wellcome Trust Sanger Institute

View shared research outputs
Top Co-Authors

Avatar

Noémie Travier

German Cancer Research Center

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Teresa Norat

Imperial College London

View shared research outputs
Top Co-Authors

Avatar

Laudina Rodríguez

International Agency for Research on Cancer

View shared research outputs
Top Co-Authors

Avatar

Nadia Slimani

International Agency for Research on Cancer

View shared research outputs
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge